Trials / Conditions / Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
3 registered clinical trials studyying Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory NCT04952584 | Baylor College of Medicine | Phase 1 |
| Recruiting | Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas NCT04288726 | Baylor College of Medicine | Phase 1 |
| Unknown | Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type NCT02560441 | Chinese Academy of Medical Sciences | Phase 2 |